Global Cell Line Development Services Market By Product Type (Reagents and Media, and Others), By Application (Bioproduction and Others), By Source (Mammalian Cell Line, Non-Mammalian Cell Line) and By Region - Global Forecast to 2030

The Cell Line Development Services Market report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market.

Request Covid - 19 Impact

The Cell Line Development Services Market report presents a thorough study of revenues, historical data, information, key developments, and strategies by major players that offer vital insights and perspectives into various scenarios market.

Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries.

It also covers threats or challenges for existing as well as new entrants in the market. The global cell line development services market has been segmented on the basis of product type, type, application, source, as well as regions, and countries.

Cell Line Development Services Market Overview:

The Cell Line Development Services Market was valued at $21.40 million in 2021 & is projected to reach $54.52 million by 2027. It is expected to grow at a 12.4% CAGR between 2021 and 2027.

Cell line development requires the discovery of single cell-derived clones that produce high and consistent levels of the target therapeutic protein.

Cell lines have revolutionized scientific research and are presently being used in vaccine production, testing drug metabolism, and cytotoxicity, the generation of artificial tissue, the study of gene function, antibody production, etc.

Cell line development services enable researchers to benefit from the advantages of comprehensive workflows that can begin from the desired gene sequence to the stable cell line, including verification procedures.

Cell Line Development Services Market Dynamics:

The increasing demand for biosimilars and biologics, as well as the growing prominence of immunology disorders across the world, are some of the primary factors that are expected to fuel the revenue growth of the global cell line development services market over the next decade.

Moreover, the steady spike in the number of research initiatives being undertaken across the world is leading to a subsequent increase in the demand for cell line development services, thereby. significantly contributing to future market growth opportunities for this global industry.

In light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies.

The global cell line development services market is no different, and the industry did feel the impact of this pandemic.

However, as ongoing studies and trials are being carried out to find an effective vaccine, the demand for these services has exponentially increased, and the global cell line development services industry is expected to benefit in the years to come.

Nonetheless, the various complexities that are involved in the development of cell lines and the high-risk potential of tainted samples are some of the factors that may restrain the revenue growth of the global cell line development services market in the foreseeable future.

Regardless, the ever-surging demand for highly productive and stable lines for both market players and potential non-industry players is another factor that is anticipated to continue to influence the revenue growth of the global cell line development services market in the foreseeable future.

Segmentation of the global cell line development services market is as follows:

In terms of product type, the reagents & media segment accounted for the maximum number of revenue shares of the global cell line development services market in 2020 and is expected to continue doing so over the forecast period. The equipment segment is also anticipated to index a high CAGR over the next 10 years.

With regards to type, the recombinant cell lines segment accounted for the highest number of revenue shares of the global cell line development services market in 2020 and is anticipated to register the highest CAGR over the next decade. The hybridomas segment is also expected to register considerable revenue growth in the years to come.

On the basis of application, the drug discovery segment accounted for the maximum number of revenue shares in 2020, and this segment is anticipated to index the highest CAGR in the coming years. The bioproduction segment is slated to account for the second-most number of revenue shares by the end of the forecast period.

With respect to source, the mammalian cell line segment accounted for the maximum number of revenue shares in 2020, and this segment is expected to continue to do so in the foreseeable future.

Cell Line Development Services Market Regional Segmentation and Analysis:

North America accounted for the maximum number of revenue shares of the global cell line development services market in 2020, and are indicative of remaining this industry’s front-runner.

The markets in Europe and the Asia Pacific regions accounted for the second-, and the third-most number of revenue shares in 2020, and are anticipated to continue doing so over the next 10 years.

Segmentation of the Global Cell Line Development Services Market:

Segmentation by Product Type:

• Reagents and Media
• Equipment
• Accessories and Consumables

Segmentation by Type:

• Recombinant Cell Lines
• Hybridisms
• Continuous Cell Lines
• Primary Cell Lines

Segmentation by Application:

• Bioproduction
• Drug Discovery
• Toxicity Testing
• Other Applications

Segmentation by Source:

• Mammalian Cell Line
• Non-Mammalian Cell Line

Segmentation by Regions:

• North America
• Europe
• APAC
• South America
• MEA